Differential deactivation of human dendritic cells by endotoxin desensitization: Role of tumor necrosis factor-α and prostaglandin E2

Blood

Volumn 91, Issue 9, 1998, Pages 3112-3117

  Rieser, Claudia ^a   Papesh, Christine ^a   Herold, Manfred ^a   Böck, Günther ^a   Ramoner, Reinhold ^a   Klocker, Helmut ^a   Bartsch, Georg ^a   Thurnher, Martin ^a  

^a Department of Urology ^*

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; DENDRITIC CELL; DESENSITIZATION; ENDOCYTOSIS; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; SEPSIS;

EID: 0032080187     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3112     Document Type: Article

References (25)

1. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272:50, 1996
2. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437, 1995
3. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 182:389, 1995
4. Verhasselt V, Buelens C, Willems F, DeGroote D, Haeffner-Cavaillon N, Goldman M: Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells - Evidence for a soluble CD 14-dependent pathway. J Immunol 158:2919, 1997
5. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994
6. Steinman RM : The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
7. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10, 1997
8. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitizution: Involvement of interleukin 10 and transforming growth factor β. J Exp Med 181:1887, 1995
9. Fraker DL, Stovroff MC, Merino MJ, Norton JA: Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 168:95, 1988
10. Döcke W-D, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: Restoration by IFN-y treatment. Nat Med 3:678, 1997
11. Rieser C, Böck G, Klocker H, Bartsch G, Thurnher M: Prostaglandin E2 and TNF-α cooperate to activate human dendritic cells: Synergistic activation of IL-12 production. J Exp Med 186:1603, 1997
12. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigens-specific adaptive immunity. Annu Rev Immunol 13:251, 1995
13. Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588, 1996
14. Romani N, Reider D, Heuer M, Ebner S, Kämpgen E, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 196:137, 1996
15. Thurnher M, Papesh C, Ramoner R, Gastl G, Böck G, Radmayr C, Klocker H, Bartsch G: In vitro generation of CD83+ human blood dendritic cells for the active tumor immunotherapy. Exp Hematol 25:232, 1997
16. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411, 1992
17. Phipps RP, Stein SH, Roper RL: A new view of prostaglandin E regulation of the immune response. Immunol Today 12:349, 1991
18. Kalinski P, Hilkens CMU, Snijders A, Snijdewint FGM, Kapsenberg ML: IL-12 deficient dendritic cells generated in the presence of prostaglandin E2 promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159:28, 1997
19. Thurnher M, Ramoner R, Gastl G, Radmayr C, Böck G, Herold M, Klocker H, Bartsch G: Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer 70:128, 1997
20. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747, 1996
21. Gimnii CD, Freeman GJ, Gribben JG, Gray G, Nadler LM: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 90:6586, 1993
22. Hilkens CMU, Kalinski P, de Boer M, Kapsenberg ML: Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90:1920, 1997
23. Bradley LM, Dalton DK, Croft M: A direct role for IFN-y in regulation of Th1 cell development. J Immunol 157:1350, 1996
24. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127, 1991
25. Berman RM, Suzuki T, Tahara H, Robbins PD, Narula SK, Lotze MT: Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J Immunol 157:231, 1996